Identification of mangiferin as a potential Glucokinase activator by structure-based virtual ligand screening
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Identification of mangiferin as a potential Glucokinase activator by structure-based virtual ligand screening
Authors
Keywords
-
Journal
Scientific Reports
Volume 7, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-03-20
DOI
10.1038/srep44681
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Structure-based discovery of an immunomodulatory inhibitor of TLR1–TLR2 heterodimerization from a natural product-like database
- (2015) Zhangfeng Zhong et al. CHEMICAL COMMUNICATIONS
- Effects of piragliatin, a glucokinase activator, on fasting and postprandial plasma glucose in patients with type 2 diabetes mellitus
- (2015) Jianguo Zhi et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Design and Synthesis of Acetylenyl Benzamide Derivatives as Novel Glucokinase Activators for the Treatment of T2DM
- (2015) Kaapjoo Park et al. ACS Medicinal Chemistry Letters
- Protein HESylation for half-life extension: Synthesis, characterization and pharmacokinetics of HESylated anakinra
- (2014) Robert Liebner et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Recent Updates on Glucokinase Activators for the Treatment of Type 2 Diabetes Mellitus
- (2014) Ajmer Grewal et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
- Programmable DNA-binding proteins from Burkholderia provide a fresh perspective on the TALE-like repeat domain
- (2014) O. d. Lange et al. NUCLEIC ACIDS RESEARCH
- Discovery of Novel Ligands for Mouse Olfactory Receptor MOR42-3 Using an In Silico Screening Approach and In Vitro Validation
- (2014) Selvan Bavan et al. PLoS One
- Berberine Promotes Glucose Consumption Independently of AMP-Activated Protein Kinase Activation
- (2014) Miao Xu et al. PLoS One
- Potent hepatitis C inhibitors bind directly to NS5A and reduce its affinity for RNA
- (2014) David B. Ascher et al. Scientific Reports
- GKAs for diabetes therapy: why no clinically useful drug after two decades of trying?
- (2013) Franz M. Matschinsky TRENDS IN PHARMACOLOGICAL SCIENCES
- ZINC: A Free Tool to Discover Chemistry for Biology
- (2012) John J. Irwin et al. Journal of Chemical Information and Modeling
- Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010
- (2012) Rafael Lozano et al. LANCET
- Designing glucokinase activators with reduced hypoglycemia risk: discovery of N,N-dimethyl-5-(2-methyl-6-((5-methylpyrazin-2-yl)-carbamoyl)benzofuran-4-yloxy)pyrimidine-2-carboxamide as a clinical candidate for the treatment of type 2 diabetes mellitus
- (2011) Jeffrey A. Pfefferkorn et al. MedChemComm
- Piragliatin (RO4389620), a Novel Glucokinase Activator, Lowers Plasma Glucose Both in the Postabsorptive State and after a Glucose Challenge in Patients with Type 2 Diabetes Mellitus: A Mechanistic Study
- (2010) Riccardo C. Bonadonna et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Diagnosis and Classification of Diabetes Mellitus
- (2009) DIABETES CARE
- Assessing the potential of glucokinase activators in diabetes therapy
- (2009) Franz M. Matschinsky NATURE REVIEWS DRUG DISCOVERY
- Glucokinase activators in diabetes management
- (2008) Matthew Coghlan et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- A new method for ligand docking to flexible receptors by dual alanine scanning and refinement (SCARE)
- (2008) Giovanni Bottegoni et al. JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now